Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-02 Sale |
2023-03-06 6:49 pm |
Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO |
15,679 | $3.627 | $56,868 | 750,728 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 6:48 pm |
Atara Biotherapeutics Inc. | ATRA | Murugan Amar SVP, GC & Secretary |
4,221 | $3.627 | $15,310 | 279,334 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 6:47 pm |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
6,871 | $3.627 | $24,921 | 181,978 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 6:46 pm |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
5,074 | $3.627 | $18,403 | 290,794 (Direct) |
View |
| 2023-02-07 Sale |
2023-02-09 5:00 pm |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
2,485 | $5.46 | $13,568 | 188,849 (Direct) |
View |
| 2022-11-16 Sale |
2022-11-18 8:13 pm |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
4,342 | $4.4903 | $19,497 | 154,540 (Direct) |
View |
| 2022-11-16 Sale |
2022-11-18 8:13 pm |
Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO |
15,591 | $4.49 | $70,004 | 441,696 (Direct) |
View |
| 2022-11-16 Sale |
2022-11-18 8:13 pm |
Atara Biotherapeutics Inc. | ATRA | Murugan Amar SVP, GC & Secretary |
3,612 | $4.49 | $16,218 | 127,586 (Direct) |
View |
| 2022-11-16 Sale |
2022-11-18 8:13 pm |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
6,255 | $4.4902 | $28,086 | 191,334 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-18 6:24 pm |
Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO |
14,806 | $5.035 | $74,548 | 457,287 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-18 6:21 pm |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
4,124 | $5.034 | $20,760 | 158,882 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-18 6:21 pm |
Atara Biotherapeutics Inc. | ATRA | Murugan Amar SVP, GC & Secretary |
3,430 | $5.0347 | $17,269 | 131,198 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-18 6:20 pm |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
5,940 | $5.035 | $29,908 | 197,589 (Direct) |
View |
| 2022-06-27 Sale |
2022-06-29 4:48 pm |
Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO |
14,220 | $7.2 | $102,384 | 472,093 (Direct) |
View |
| 2022-06-08 Sale |
2022-06-10 4:20 pm |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
5,853 | $5.63 | $32,952 | 203,529 (Direct) |
View |
| 2022-05-17 Sale |
2022-05-19 5:20 pm |
Atara Biotherapeutics Inc. | ATRA | Murugan Amar SVP, GC & Secretary |
3,223 | $5.3163 | $17,134 | 133,735 (Direct) |
View |
| 2022-05-17 Sale |
2022-05-19 5:16 pm |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
5,582 | $5.3162 | $29,675 | 207,592 (Direct) |
View |
| 2022-05-17 Sale |
2022-05-19 5:08 pm |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
3,873 | $5.318 | $20,597 | 163,006 (Direct) |
View |
| 2022-05-17 Sale |
2022-05-19 5:04 pm |
Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO |
13,913 | $5.316 | $73,962 | 486,313 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 7:02 pm |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
3,763 | $9.8564 | $37,090 | 328,281 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 7:02 pm |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
2,221 | $9.856 | $21,890 | 314,452 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 7:02 pm |
Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO |
8,828 | $9.856 | $87,009 | 839,645 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 7:02 pm |
Atara Biotherapeutics Inc. | ATRA | Murugan Amar SVP, GC & Secretary |
2,577 | $9.8566 | $25,400 | 234,356 (Direct) |
View |
| 2022-02-10 Sale |
2022-02-14 5:42 pm |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
5,000 | $16 | $80,000 | 348,094 (Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 4:35 pm |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
2,496 | $14.46 | $36,096 | 155,702 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-01 Option Award |
2023-03-03 5:16 pm |
N/A 2033-02-28 |
Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO |
1,055,311 | $0 | 1,497,007 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:16 pm |
N/A 2033-02-28 |
Atara Biotherapeutics Inc. | ATRA | Banard Charlene A. EVP, Chief Technical Officer |
454,025 | $0 | 609,375 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:15 pm |
N/A 2033-02-28 |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
459,315 | $0 | 613,855 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:15 pm |
N/A 2033-02-28 |
Atara Biotherapeutics Inc. | ATRA | Murugan Amar SVP, GC & Secretary |
504,968 | $0 | 633,148 (Direct) |
View |
Ownership |
2022-12-16 5:43 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Banard Charlene A. EVP, Chief Technical Officer |
0 | $0 | 447,373 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | Gallagher Carol Giltner Director |
52,000 | $0 | 163,918 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | HEIDEN WILLIAM K Director |
52,000 | $0 | 83,500 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director |
52,000 | $0 | 83,500 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | MALLIK AMEET Director |
52,000 | $0 | 52,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | Roncarolo Maria Grazia Director |
52,000 | $0 | 63,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | Baynes Roy D. Director |
52,000 | $0 | 75,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | DOBMEIER ERIC Director |
52,000 | $0 | 91,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | Renaud Ronald C JR Director |
52,000 | $0 | 63,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | SEIDENBERG BETH C Director |
52,000 | $0 | 1,967,233 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 7:02 pm |
N/A 2032-02-28 |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal Chief Financial Officer |
176,342 | $0 | 328,281 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 7:02 pm |
N/A 2032-02-28 |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
226,079 | $0 | 314,452 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 7:02 pm |
N/A 2032-02-28 |
Atara Biotherapeutics Inc. | ATRA | Yarema Kristin Chief Commercial Officer |
131,125 | $0 | 257,007 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 7:02 pm |
N/A 2032-02-28 |
Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO |
519,984 | $0 | 839,645 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 7:02 pm |
N/A 2032-02-28 |
Atara Biotherapeutics Inc. | ATRA | Murugan Amar SVP, GC & Secretary |
149,212 | $0 | 234,356 (Direct) |
View |
| 2022-02-10 Exercise |
2022-02-14 5:42 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
5,000 | $9.58 | 348,094 (Direct) |
View |
| 2022-02-10 Exercise |
2022-02-14 5:42 pm |
N/A 2030-05-13 |
Atara Biotherapeutics Inc. | ATRA | Dupont Jakob EVP, Head of R&D |
5,000 | $0 | 348,094 (Direct) |
View |